Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway
Nutrients · 27.10.2023 · 15 (21) · 4574
DOI: 10.3390/nu15214574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 27.10.2023. Verfasst von Kyung Eun Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727…. Hauptthemen laut MEDLINE: Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Basic Science Institute.
Abstract (Originalsprache)
An intermittent fasting (IF) regimen has been shown to protect against metabolic dysfunction-associated steatohepatitis (MASH). However, the precise mechanism remains unclear. Here, we explored how IF reduced hepatic lipid accumulation, inflammation, and fibrosis in mice with MASH. The mice were fed a high-fat diet (HFD) for 30 weeks and either continued on the HFD or were subjected to IF for the final 22 weeks. IF reduced body weight, insulin resistance, and hepatic lipid accumulation in HFD-fed mice. Lipidome analysis revealed that IF modified HFD-induced hepatic lipid composition. In particular, HFD-induced impaired autophagic flux was reversed by IF. The decreased hepatic lysosome-associated membrane protein 1 level in HFD-fed mice was upregulated in HFD+IF-fed mice. However, increased hepatic lysosomal acid lipase protein levels in HFD-fed mice were reduced by IF. IF attenuated HFD-induced hepatic inflammation and galectin-3-positive Kupffer cells. In addition to the increases in hepatic hydroxyproline and lumican levels, lipocalin-2-mediated signaling was reversed in HFD-fed mice by IF. Taken together, our findings indicate that the enhancement of the autophagy–lysosomal pathway may be a critical mechanism of MASH reduction by IF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.
- Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul 03759, Republic of Korea.
- College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
ORCID-Profile: Gu Seob Roh
Förderung
- National Research Foundation of Korea
- Korea Basic Science Institute
Zitieren
APA
Kim, K. E., Shin, H. J., Ju, Y., Jung, Y., An, H. S., Lee, S. J., Jeong, E. A., Lee, J., Hwang, G. S., & Roh, G. S. (2023). Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway. Nutrients, 15(21), 4574. https://doi.org/10.3390/nu15214574
Vancouver
Kim KE, Shin HJ, Ju Y, Jung Y, An HS, Lee SJ, et al. Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway. Nutrients. 2023;15(21):4574. doi:10.3390/nu15214574
BibTeX
@article{Kim2023,
author = {Kim, Kyung Eun and Shin, Hyun Joo and Ju, Yeajin and Jung, Youngae and An, Hyeong Seok and Lee, So Jeong and Jeong, Eun Ae and Lee, Jaewoong and Hwang, Geum-Sook and Roh, Gu Seob},
title = {Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {21},
pages = {4574},
doi = {10.3390/nu15214574}
}
EUVIMED